MLICM
SLRN

Metropolitan Life Insurance Company (MetLife)’s ACELYRIN SLRN Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,931
Closed -$26.5K – 1792
2024
Q1 		$26.5K Buy
3,931
+1,927
+96% +$14.6K ﹤0.01% 1720
2023
Q4 		$14.9K Hold
2,004
– – ﹤0.01% 2039
2023
Q3 		$20.4K Buy
+2,004
New +$42.6K ﹤0.01% 1890

Other funds holding SLRN

ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $334M AUM 258.79% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s SLRN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of ACELYRIN (SLRN) in Q2 2024, closing a stake of 3,931 shares — an estimated $26.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SLRN in Q3 2023 and held it in 3 quarters. The position peaked at $26.5K in Q1 2024. 112 funds tracked by Wall St. Rank hold SLRN as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining ACELYRIN position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,931 ACELYRIN shares in Q2 2024, an estimated $26.5K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in ACELYRIN in Q3 2023 and held it in 3 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s ACELYRIN position peaked at $26.5K in Q1 2024.
  • 112 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.